(Q44539907)

English

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms

scientific article published on 20 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

0 references

MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

S A Owen

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

J Bowes

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

S L Hider

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

20 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

The Pharmacogenomics Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

137-147

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1038/tpj.2011.42

0 references

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR)

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Pharmacogenetic study of 5,10-methylenetetrahydrofolate reductase C677T and thymidylate synthase 3R/2R gene polymorphisms and methotrexate-related toxicity in Chinese Han patients with inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Associations between the C677T and A1298C polymorphisms of MTHFR and the efficacy and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Meta-analysis of genetic association studies.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Methylenetetrahydrofolate reductase and reduced folate carrier-1 genotypes and methotrexate serum concentrations in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Preliminary study to identify the predictive factors for the response to methotrexate therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Polymorphisms C677T and A1298C in the MTHFR gene in Mexican patients with rheumatoid arthritis treated with methotrexate: implication with elevation of transaminases.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Serum folate and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism adjusted for folate intake

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Current status of prenatal management of fetal spina bifida in the world: worldwide cooperative survey on the medico-ethical issue

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Dietary folate intake during pregnancy and birth weight in Japan.

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2011.42

21 January 2018

Identifiers

10.1038/TPJ.2011.42

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44539907&oldid=2027122235"